Sorafenib for hepatocellular carcinoma patients beyond Milan criteria after orthotopic liver transplantation: a case control study
about
Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A reviewCarbon nanotubes: an emerging drug carrier for targeting cancer cellsManagement of hepatocellular carcinoma: Enlightening the gray zones.Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome.Use of adjuvant sorafenib in liver transplant recipients with high-risk hepatocellular carcinoma.Sorafenib use in the transplant setting.Hepatocellular carcinoma in patients listed for liver transplantation: Current and future allocation policy and management strategies for the individual patient.Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival.Efficacy of combination treatment modalities for intermediate and advanced hepatocellular carcinoma: intra-arterial therapies, sorafenib and novel small molecules.The reprogramming therapy for a patient with advanced hepatocellular carcinoma by using human-induced pluripotent stem (iPS) cells technology.[Tumor and transplantation].
P2860
Q26750463-908B4C4E-B58B-4493-B7B0-6D2A38C7FB89Q28385865-E89CD65C-B728-4BDD-A123-0F0B746B2F13Q36955647-72BF5341-C753-44D2-A1A4-208569CB2C4DQ36962089-CDFC160F-E0D5-413C-8902-B8CB59DCBB4DQ37730611-974EB736-7814-4BB8-A517-7A167DE1201BQ38210270-46D30604-C53A-4FA7-80EA-467167E28183Q38604896-73A0EA06-90DD-432D-B47A-67E1BD3BCE14Q38635611-E14A09AD-46D5-46A7-8C5A-D4458DDC11AAQ40389227-A538AC95-A19C-439F-8400-37037B45C7AAQ41355820-E10E8982-0F79-443C-9345-6CCC4521588FQ44547715-92A511B6-0C19-48C2-A650-7B72B14C1BE4
P2860
Sorafenib for hepatocellular carcinoma patients beyond Milan criteria after orthotopic liver transplantation: a case control study
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Sorafenib for hepatocellular c ...... antation: a case control study
@ast
Sorafenib for hepatocellular c ...... antation: a case control study
@en
type
label
Sorafenib for hepatocellular c ...... antation: a case control study
@ast
Sorafenib for hepatocellular c ...... antation: a case control study
@en
prefLabel
Sorafenib for hepatocellular c ...... antation: a case control study
@ast
Sorafenib for hepatocellular c ...... antation: a case control study
@en
P2093
P2860
P356
P1476
Sorafenib for hepatocellular c ...... antation: a case control study
@en
P2093
Chieh-Lin Teng
Kuang-Hsi Chang
Shao-Bin Cheng
Wen-Li Hwang
Yi-Ju Chen
P2860
P2888
P356
10.1186/1477-7819-10-41
P577
2012-02-17T00:00:00Z
P5875
P6179
1011429977